Cancer News and Research

Latest Cancer News and Research

Stanford Hospital uses new device to treat brain aneurysm

If Barbara Maluo's brain aneurysm had been discovered a few months ago, she would have had few viable treatment options. She was one of the 10 to 15 percent of brain aneurysm patients diagnosed each year with aneurysms so large and wide that they cannot be reliably treated using conventional methods of treatment.

1 Nov 2011

'Mozart Effect' may increase detection rates of precancerous polyps

Physicians who listen to Mozart while performing colonoscopy may increase their detection rates of precancerous polyps, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

1 Nov 2011

Heart disease treatment tops list of most expensive conditions for men

The cost of treating men for heart disease topped $47 billion in 2008, leading a list of the 10 most expensive conditions for men age 18 and older, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

1 Nov 2011

Tregs expansion can help prevent graft-versus-host disease

Graft-versus-host disease (GVHD) is a serious risk in many kinds of cell transplants, including for stem cell transplants carried out when stem cells are partially depleted of conventional T cells, which play an important role in the immune system. Now, researchers at Moffitt Cancer Center have tested a process by which T regulatory cells (Tregs) can be "expanded" to help prevent GVHD.

1 Nov 2011

Potential transmission of HBV, HCV and HIV infections in nail salons and barbershops

The risk of hepatitis transmission through non-single use instruments -- such as nail files, nail brushes, finger bowls, foot basins, buffers, razors, clippers, and scissors -- during nail salon and barbershop visits cannot be excluded, according to the results of a new report unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

1 Nov 2011

NCI awards ImaginAb $2.3M grant to develop PET diagnostic imaging agents

ImaginAb, Inc. is pleased to announce that it has been awarded a total of $2.3 million in funding from the National Cancer Institute's Small Business Innovation Research program to help further develop diagnostic imaging agents for Positron Emission Tomography.

1 Nov 2011

ER-positive breast cancer patients with high levels of heat shock factor 1 experience poor outcomes

Whitehead Institute scientists report that patients whose estrogen receptor (ER)-positive breast cancers have high levels of the ancient cellular survival factor heat shock factor 1 (HSF1) experience poor outcomes—including increased mortality.

1 Nov 2011

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2.

1 Nov 2011

Aspirin may reduce risk of bowel cancer by half: Study

According to a new study published in The Lancet, a regular dose of aspirin may not only stave off heart disease but also cut the risk of developing hereditary cancer in half.

31 Oct 2011

A healthy diet may help reduce risk of breast cancer

October was breast cancer awareness month and the long asked question – does diet really influence the risk of breast cancer?, is finally being answered.

31 Oct 2011

Obama to issue order to address medicine shortages

President Obama will issue an executive order on Monday that the administration hopes will help resolve a growing number of critical shortages of vital medicines used to treat life-threatening illnesses.

31 Oct 2011

New computer-based tool enables early diagnosis of cancer

A computer-based tool could help GPs to speed up the diagnosis and treatment of patients suffering from two of the most common forms of cancer, potentially saving thousands of lives every year.

31 Oct 2011

FDA grants Premarket Approval for Roche's IgM antibody to hepatitis B core antigen assay

Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.

From Roche Sequencing and Life Science 31 Oct 2011

Cigarette smokers at risk of compromised digestive function

Cigarette smoking appears to impair pancreatic duct cell function--even for those who quit--putting all smokers at risk of compromised digestive function regardless of age, gender and alcohol intake, according to the results of a study unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

31 Oct 2011

Focused training increases physician's ability to find potentially precancerous polyps

Just two extra hours of focused training significantly increased the ability of physicians to find potentially precancerous polyps, known as adenomas, in the colon, according to researchers at Mayo Clinic in Florida. These findings suggest that new methods to educate endoscopists, the physicians who examine the colon, could increase colorectal cancer detection rates and potentially reduce cancer deaths.

31 Oct 2011

iCAD, Hitachi enter distribution agreement for MRI breast cancer diagnosis and guided biopsy solution

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that it has entered into a distribution agreement with Hitachi Medical Systems.

31 Oct 2011

Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that it has earned $4 million in milestone payments upon the initiation of two Phase 1 clinical trials of IPI-145.

31 Oct 2011

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Circadian Technologies Limited announces that its 100% owned subsidiary, Vegenics Pty Ltd, has received approval for its investigational new drug application from the U.S. Food and Drug Administration to initiate clinical trials of VGX-100.

31 Oct 2011

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.

31 Oct 2011

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.

31 Oct 2011

Cancer News and Research

Latest Cancer News and Research

Stanford Hospital uses new device to treat brain aneurysm

'Mozart Effect' may increase detection rates of precancerous polyps

Heart disease treatment tops list of most expensive conditions for men

Tregs expansion can help prevent graft-versus-host disease

Potential transmission of HBV, HCV and HIV infections in nail salons and barbershops

NCI awards ImaginAb $2.3M grant to develop PET diagnostic imaging agents

ER-positive breast cancer patients with high levels of heat shock factor 1 experience poor outcomes

UCB to present new data on Cimzia at ACG annual scientific meeting

Aspirin may reduce risk of bowel cancer by half: Study

A healthy diet may help reduce risk of breast cancer

Obama to issue order to address medicine shortages

New computer-based tool enables early diagnosis of cancer

FDA grants Premarket Approval for Roche's IgM antibody to hepatitis B core antigen assay

Cigarette smokers at risk of compromised digestive function

Focused training increases physician's ability to find potentially precancerous polyps

iCAD, Hitachi enter distribution agreement for MRI breast cancer diagnosis and guided biopsy solution

Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in